排序方式:
    總頁 1 
      Go

    1.SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade (vol 9, pg 304, 2019)

    Zhao, MX, Guo, WJ, W     More...

    ACTA PHARMACEUTICA SINICA B[2211-3835], Published 2025, Volume 15, Issue 5, Pages 2810-2812

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2025影響因子:  14.6  发表年影響因子:  14.6 

    2.Targeting PKM2 signaling cascade with salvianic acid A normalizes tumor blood vessels to facilitate chemotherapeutic drug delivery

    Qian, C, Zhou, YK, Z     More...

    ACTA PHARMACEUTICA SINICA B[2211-3835], Published 2024, Volume 14, Issue 5, Pages 2077-2096

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 46  2025影響因子:  14.6  发表年影響因子:  14.6 

    3.SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade

    Zhao, MX, Guo, WJ, W     More...

    ACTA PHARMACEUTICA SINICA B[2211-3835], Published 2019, Volume 9, Issue 2, Pages 304-315

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 159  2025影響因子:  14.6  发表年影響因子:  7.097 

    顯示      條  合計   3   條
      總頁 1 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫